Table 1.
Viral Effects on apoptosis via the internal mechanism of mitochondrial influence.
ANTI-APOPTOTIC | ||
---|---|---|
Virus; protein | Mechanism | Notes |
Adenovirus; E1B-19K | Bcl-2 mimic | Han et al. (1996) |
African swine fever virus; A179L | Bcl-2 mimic | Brun et al. (1996) |
Myxoma virus; M11L | Bcl-2 mimic | Douglas et al. (2007) |
Epstein-Barr virus; BHRF1 | Bcl-2 mimic | Hickish et al. (1994) |
Human herpesvirus 8; Kaposi’s sarcoma-associated Bcl-2 | Bcl-2 mimic | Cheng et al. (1997) |
Cytomegalovirus; vMIA | PTPC inhibition | Goldmacher (2002) |
SARS-CoV-1; NSP15 | Inhibited MAVS-induced apoptosis | Dose-dependent and with specificity as it did not inhibit staurosporine-induced apoptosis Lei et al. (2009). |
PRO-APOPTOTIC | ||
Virus; protein | Mechanism | Notes |
Human papillomavirus; E1 and E4 | Disrupt the intracellular keratin network and cause mitochondria to accumulate next to the nucleus and lose MMP | Doorbar et al. (1991) |
Vesicular stomatitis virus; matrix protein M | Interfere with the Bcl-2 family | Gadaleta et al. (2005) |
Avian encephalomyelitis virus; 2C | Activates caspase-9 | Liu et al. (2004) |
Hepatitis C virus; NS4A | Disrupts MMP | Nomura-Takigawa et al. (2006) |
Hepatitis C virus; NS3 | Induces caspase-8 | Prikhod’ko et al. (2004) |
Influenza A; PB1-F2 | Disrupts MMP | Chanturiya et al. (2004) |
Human immunodeficiency virus type 1; Vpr | Rapid dissipation of the MMP and interaction with components of the PTPC | Jacotot et al. (2000) |
SARS-CoV-1; gene 7a | Inhibit antiapoptotic Bcl-xL in cultured cells | Schaecher et al. (2007) |
SARS-CoV-1; ORF-6 | Induce caspase-3 mediated apoptosis | Ye et al. (2008) |